Prescription Drug Boxed Warnings: Impact on Firms, Physicians, and Patients

Wednesday, June 15, 2016: 8:30 AM-10:00 AM
G17 (Claudia Cohen Hall)
Marta Wosinska
8:30 AM
The Impact of Public Information and FDA Issued Warnings on the Use of Antidepressants in Primary Care

Author(s): W. David Bradford; Andrew N Kleit

Discussant: Marisa E. Domino

8:50 AM
How Physicians Respond to Information Shocks: The Role of Physician Characteristics in Boxed Warning Response

Author(s): Lisa M. Selker; Stacie B. Dusetzina; Marisa E. Domino; G. Caleb Alexander; G. Mark Holmes

Discussant: W. David Bradford

9:10 AM
The ‘Black Box' of Strategy: Competitive Responses to and Performance from Adverse Regulatory Events

Author(s): Jeffrey T Macher; James B Wade

Discussant: Sara Markowitz

See more of: Prescription Drugs